Filing Details

Accession Number:
0000939767-19-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-11 19:56:17
Reporting Period:
2019-01-10
Accepted Time:
2019-01-11 19:56:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
939767 Exelixis Inc. EXEL Services-Commercial Physical & Biological Research (8731) 043257395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1692954 J. Patrick Haley C/O Exelixis, Inc.
1851 Harbor Bay Parkway
Alameda CA 94502
Sr. Vice President, Commercial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-10 2,000 $1.76 99,011 No 4 M Direct
Common Stock Disposition 2019-01-10 2,000 $24.00 97,011 No 4 S Direct
Common Stock Disposition 2019-01-10 1,000 $23.54 96,011 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2019-01-10 2,000 $0.00 2,000 $1.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,375 2015-11-17 2021-11-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 23,539 Indirect By spouse
Common Stock 10,283 Indirect By 401(k)
Footnotes
  1. Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018.
  3. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of January 9, 2019.
  4. The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018.